Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $10.28, for a total transaction of $1,517,132.68. Following the sale, the insider now owns 10,738,564 shares of the company’s stock, valued at approximately $110,392,437.92. The trade was a 1.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Paragon 28 Stock Down 3.7 %
FNA stock opened at $10.04 on Monday. Paragon 28, Inc. has a one year low of $4.65 and a one year high of $14.79. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. The firm’s fifty day moving average is $6.71 and its 200 day moving average is $7.21. The firm has a market cap of $840.55 million, a PE ratio of -13.57 and a beta of 1.01.
Paragon 28 (NYSE:FNA – Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01. The firm had revenue of $62.30 million for the quarter, compared to analysts’ expectations of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period last year, the firm earned ($0.10) EPS. On average, research analysts forecast that Paragon 28, Inc. will post -0.66 EPS for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on FNA. Needham & Company LLC boosted their target price on shares of Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Canaccord Genuity Group decreased their price objective on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $12.00 target price (down from $15.00) on shares of Paragon 28 in a report on Friday, August 9th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $15.60.
Read Our Latest Research Report on Paragon 28
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Articles
- Five stocks we like better than Paragon 28
- What Are Dividend Contenders? Investing in Dividend Contenders
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Consumer Staples Stocks, Explained
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.